Lupin Ltd (LUPN)

Currency in INR
1,865.45
-63.35(-3.28%)
Closed·
LUPN Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
LUPN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,861.151,928.75
52 wk Range
1,774.002,403.45
Key Statistics
Bid/Ask
1,868.00 / 1,871.30
Prev. Close
1,928.8
Open
1,925.05
Day's Range
1,861.15-1,928.75
52 wk Range
1,774-2,403.45
Volume
27.8K
Average Volume (3m)
30.09K
1-Year Change
-4.85%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LUPN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2,230.43
Upside
+19.57%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Lupin Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Lupin Ltd Company Profile

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company also offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, women’s health, and central nervous system areas, as well as pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies. In addition, it focuses on various therapeutic spectrum, including rheumatology, oncology, neuroscience, and renal therapies. Further, the company is involved in the provision of diagnostics services, and digital healthcare services; and neuro rehabilition business. It operates through network consists of labs and collection centers. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Employees
24006
Market
India

Compare LUPN to Peers and Sector

Metrics to compare
LUPN
Peers
Sector
Relationship
P/E Ratio
26.0x32.3x−0.5x
PEG Ratio
0.361.370.00
Price/Book
5.0x5.3x2.6x
Price / LTM Sales
3.8x4.4x3.3x
Upside (Analyst Target)
21.4%8.9%45.4%
Fair Value Upside
Unlock−2.0%7.7%Unlock

Analyst Ratings

20 Buy
13 Hold
4 Sell
Ratings:
37 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2,230.43
(+19.57% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 71.95%
Dividend Yield
0.64%
Industry Median 0.73%
Annualised payout
12.00
Paid annually
5-Years Growth
+14.87%
Growth Streak

Earnings

Latest Release
May 14, 2025
EPS / Forecast
18.30 / 16.74
Revenue / Forecast
56.67B / 55.26B
EPS Revisions
Last 90 days

LUPN Income Statement

People Also Watch

377.20
BAJE
-1.54%
3,159.30
MAHM
-1.37%
235.13
BOB
-1.15%
6,361.50
DIVI
-3.55%
388.70
RECM
-1.64%

FAQ

What Stock Exchange Does Lupin Ltd Trade On?

Lupin Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Lupin Ltd?

The stock symbol for Lupin Ltd is "LUPN."

What Is the Lupin Ltd Market Cap?

As of today, Lupin Ltd market cap is 852.04B.

What Is Lupin Ltd's Earnings Per Share (TTM)?

The Lupin Ltd EPS (TTM) is 71.95.

When Is the Next Lupin Ltd Earnings Date?

Lupin Ltd will release its next earnings report on 04 Aug 2025.

From a Technical Analysis Perspective, Is LUPN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Lupin Ltd Stock Split?

Lupin Ltd has split 2 times.

How Many Employees Does Lupin Ltd Have?

Lupin Ltd has 24006 employees.

What is the current trading status of Lupin Ltd (LUPN)?

As of 03 Aug 2025, Lupin Ltd (LUPN) is trading at a price of 1,865.45, with a previous close of 1,928.80. The stock has fluctuated within a day range of 1,861.15 to 1,928.75, while its 52-week range spans from 1,774.00 to 2,403.45.

What Is Lupin Ltd (LUPN) Price Target According to Analysts?

The average 12-month price target for Lupin Ltd is INR2230.43243, with a high estimate of INR2626 and a low estimate of INR1731. 20 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Buy. The stock has an +19.57% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.